ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

Efficient and safe in vivo treatment of primary hyperoxaluria type 1 via LNP-CRISPR-Cas9-mediated glycolate oxidase disruption.

Yanhong Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.